Intellipharmaceutics International Inc. Quarterly Share-based Payment Arrangement, Expense in CAD from Q1 2016 to Q2 2017

Taxonomy & unit
us-gaap: CAD and USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Intellipharmaceutics International Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2016 to Q2 2017.
  • Intellipharmaceutics International Inc. Share-based Payment Arrangement, Expense for the quarter ending May 31, 2017 was CA$822K, a 1917% increase year-over-year.
  • Intellipharmaceutics International Inc. annual Share-based Payment Arrangement, Expense for 2018 was CA$928K, a 47% decline from 2017.
  • Intellipharmaceutics International Inc. annual Share-based Payment Arrangement, Expense for 2017 was CA$1.75M, a 22.6% decline from 2016.
  • Intellipharmaceutics International Inc. annual Share-based Payment Arrangement, Expense for 2016 was CA$2.26M, a 441% increase from 2015.
Share-based Payment Arrangement, Expense, Quarterly (CAD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2017 822K +781K +1917% Mar 1, 2017 May 31, 2017 6-K 2017-07-11
Q1 2017 823K +163K +24.7% Dec 1, 2016 Feb 28, 2017 6-K 2017-04-12
Q2 2016 40.7K Mar 1, 2016 May 31, 2016 6-K 2017-07-11
Q1 2016 660K Dec 1, 2015 Feb 29, 2016 6-K 2017-04-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.